This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Spinner MA, Sanchez LA, Hsu AP, Shaw PA, Zerbe CS, Calvo KR et al. GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity. Blood 2014; 123: 809–821.
Vinh DC, Patel SY, Uzel G, Anderson VL, Freeman AF, Olivier KN et al. Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia. Blood 2010; 115: 1519–1529.
Hsu AP, Sampaio EP, Khan J, Calvo KR, Lemieux JE, Patel SY et al. Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood 2011; 118: 2653–2655.
Pasquet M, Bellanne-Chantelot C, Tavitian S, Prade N, Beaupain B, Larochelle O et al. High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemia. Blood 2013; 121: 822–829.
Kazenwadel J, Secker GA, Liu YJ, Rosenfeld JA, Wildin RS, Cuellar-Rodriguez J et al. Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature. Blood 2012; 119: 1283–1291.
Dickinson RE, Griffin H, Bigley V, Reynard LN, Hussain R, Haniffa M et al. Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency. Blood 2011; 118: 2656–2658.
Wlodarski MW, Hirabayashi S, Pastor V, Stary J, Hasle H, Masetti R et al. Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents. Blood 2016; 127: 1387–1397.
Wang X, Muramatsu H, Okuno Y, Sakaguchi H, Yoshida K, Kawashima N et al. GATA2 and secondary mutations in familial myelodysplastic syndromes and pediatric myeloid malignancies. Haematologica 2015; 100: e398–e401.
Vicente C, Conchillo A, Garcia-Sanchez MA, Odero MD . The role of the GATA2 transcription factor in normal and malignant hematopoiesis. Crit Rev Oncol Hematol 2012; 82: 1–17.
Collin M, Dickinson R, Bigley V . Haematopoietic and immune defects associated with GATA2 mutation. Br J Haematol 2015; 169: 173–187.
Hahn CN, Chong CE, Carmichael CL, Wilkins EJ, Brautigan PJ, Li XC et al. Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nat Genet 2011; 43: 1012–1017.
Shiba N, Funato M, Ohki K, Park MJ, Mizushima Y, Adachi S et al. Mutations of the GATA2 and CEBPA genes in paediatric acute myeloid leukaemia. Br J Haematol 2014; 164: 142–145.
Dickinson RE, Milne P, Jardine L, Zandi S, Swierczek SI, McGovern N et al. The evolution of cellular deficiency in GATA2 mutation. Blood 2014; 123: 863–874.
Micol JB, Abdel-Wahab O . Collaborating constitutive and somatic genetic events in myeloid malignancies: ASXL1 mutations in patients with germline GATA2 mutations. Haematologica 2014; 99: 201–203.
West RR, Hsu AP, Holland SM, Cuellar-Rodriguez J, Hickstein DD . Acquired ASXL1 mutations are common in patients with inherited GATA2 mutations and correlate with myeloid transformation. Haematologica 2014; 99: 276–281.
Acknowledgements
This research is supported by the National Research Foundation Singapore under its Singapore Translational Research (STaR) Investigator Award (NMRC/STaR/0021/2014) and administered by the Singapore Ministry of Health’s National Medical Research Council (NMRC), the NMRC Centre Grant awarded to National University Cancer Institute of Singapore, the National Research Foundation Singapore and the Singapore Ministry of Education under its Research Centres of Excellence initiatives. This research is supported by the National Institutes of Health of the USA (R01CA026038-35), as well as by a generous donation from the Melamed family.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on the Leukemia website
Supplementary information
Rights and permissions
About this article
Cite this article
Ding, LW., Ikezoe, T., Tan, KT. et al. Mutational profiling of a MonoMAC syndrome family with GATA2 deficiency. Leukemia 31, 244–245 (2017). https://doi.org/10.1038/leu.2016.256
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2016.256
This article is cited by
-
Prognostic significance of GATA2 in patients with MDS/AML: a systematic review and meta-analysis
Annals of Hematology (2024)
-
Role of the pioneer transcription factor GATA2 in health and disease
Journal of Molecular Medicine (2023)
-
Differential effects on gene transcription and hematopoietic differentiation correlate with GATA2 mutant disease phenotypes
Leukemia (2018)
-
Familial Acute Myeloid Leukemia and Myelodysplasia in Hungary
Pathology & Oncology Research (2018)
-
Allogeneic hematopoietic cell transplantation in patients with GATA2 deficiency—a case report and comprehensive review of the literature
Annals of Hematology (2018)